Skip to main content
Jennifer Swettenham

Dr Jennifer Swettenham

Neuroscience Portfolio Manager

School of Biosciences


I am the Neuroscience Portfolio Manager working in the Medicines Discovery Institute at Cardiff University. I manage the neuroscience drug discovery projects, liaising and collaborating with our research partners to ensure project milestones are delivered.

I project manage the First-In-Human Phase 1 clinical trial of MDI-26478 - a novel compound being developed as a treatment for Cognitive Impairment Associated with Schizophrenia (CIAS). This trial will test the safety and tolerability of MDI-26478 in healthy volunteers, and the trial will also use the neuroimaging facilities at CUBRIC to show how MDI-26478 affects the brain.

Previously, I was a Clinical Trial Manager in the Cancer Group of the Centre for Trials Research (CTR). There I developed and managed early phase trials, mainly in gynaecological cancers. Prior to that, I was the trial manager for research investigating disorders of localised fibrosis at the Oxford Clinical Trials Research Unit (OCTRU), and the Infectious Diseases Trial Co-ordinator at the Primary Care Clinical Trials Unit (University of Oxford).

My background is in neuroscience and I have more than ten years’ experience of running human behavioural and neuroimaging (magnetoencephalography (MEG) and magnetic resonance imaging (MRI)) studies. My postdoctoral research at CUBRIC (Cardiff University Brain Research Imaging Centre) investigated visual processing in the brain. Then, as Research Facilitator at OHBA (Oxford centre for Human Brain Activity), I trained researchers and helped them develop their studies. I have worked on many studies covering a wide range of cognitive processes in both the healthy and non-typical brain.











Career overview

  • 2019-present: Neuroscience Portfolio Manager, Medicines Discovery Institute, Cardiff University, UK.
  • 2017-2019: Clinical Trial Manager, Solid Tumours, Centre for Trials Research, Cardiff University, UK.
  • 2015-2017: Clinical Trial Manager, Oxford Clinical Trials Research Unit (OCTRU), University of Oxford, UK.
  • 2014-2015: Clinical Trial Coordinator: Primary Care Clinical Trials Unit (PC-CTU), University of Oxford, UK.
  • 2011-2014: Research Facilitator: The Oxford Centre for Human Brain Activity (OHBA), University of Oxford, UK.
  • 2010-2011: Visiting Lecturer: Aston University, UK.
  • 2009-2011: Post-doctoral Research Associate: Studies of autism spectrum disorder (ASD), University of Oxford, UK.
  • 2006-2009: Post-doctoral Research Associate: Cardiff University Brain and Repair Imaging Centre (CUBRIC), Cardiff University, UK.
  • 2000-2001: Laboratory Manager at Weston Medical Ltd., Eye, UK.

Education and qualifications

  • 2001-2006: PhD: ‘Functional neuroimaging and behavioural studies on global form processing in the human visual system’: Aston University, UK.
  • 1996-2000: BSc (Hons) Neuroscience 1st Class at University of Nottingham, UK.
  • 1998-1999: Industrial Placement Student at Eli Lilly and Co., Windlesham, UK.